Skip to main content

Day: March 23, 2021

DeFi Technologies Signs LOI to Acquire remaining 80% Interest in Valour Structured Products, a leading Exchange Traded Products issuer with a focus on digital assets

TORONTO, March 23, 2021 (GLOBE NEWSWIRE) — DeFi Technologies Inc. (the “Company” or “DeFi Technologies”) (NEO: DEFI, GR: RMJR) is pleased to announce it has entered into a binding Letter of Intent (“LOI”) to acquire a 80% equity interest in Valour Structured Products, Inc. (“Valour”) from certain shareholders of Valour (“Acquisition”). The Company currently holds a 20% interest in Valour and following the Acquisition, Valour will become a wholly owned subsidiary of DeFi Technologies. The LOI contemplates that DeFi Technologies and Valour will promptly negotiate and enter into a definitive agreement (“Definitive Agreement”), together with such other documents that may be required in order to formalize and execute the terms of the Acquisition as outlined in the LOI. Valour Highlights:Bitcoin Zero started trading on December 3rd,...

Continue reading

Troilus to Acquire UrbanGold Minerals in All-Share Transaction

TORONTO, March 23, 2021 (GLOBE NEWSWIRE) — Troilus Gold Corp. (TSX: TLG) (OTCQB: CHXMF) (“Troilus” or the “Company”) and UrbanGold Minerals Inc. (TSXV: UGM) (“UrbanGold”) are pleased to announce that the companies have entered into a definitive agreement (the “Agreement”), pursuant to which Troilus has agreed to acquire all of the issued and outstanding common shares of UrbanGold (the “UrbanGold Shares”) that it does not currently own (the “Transaction”). Troilus currently owns 6,156,291 UrbanGold Shares, or approximately 9.7% of the UrbanGold Shares outstanding. The Transaction is being carried out by way of a three-cornered amalgamation (the “Amalgamation”) under the Canada Business Corporations Act (Canada). UrbanGold shareholders will be asked to vote on the Amalgamation at a special meeting of UrbanGold shareholders (the “UrbanGold...

Continue reading

TELESTE RECORDS A NON-RECURRING ITEM OF EUR 3.2 MILLION IN OTHER OPERATING INCOME

TELESTE CORPORATION               INVESTOR NEWS             23 March 2021 at 1.00 pm (EET) TELESTE RECORDS A NON-RECURRING ITEM OF EUR 3.2 MILLION IN OTHER OPERATING INCOME Teleste records a non-recurring item of EUR 3.2 million in other operating income in the first quarter of 2021. The income relates to the crime incident announced in March 2019. The company is able to recover EUR 3.2 million as a settlement with insurance companies during the first quarter of 2021 in addition to recovered funds reported in the financial statements of 2019 (recovered funds in total EUR 3.9 million). The company estimates that additional recovery of the funds lost due to the crime incident is unlikely in the future. The company reports the non-recurring income as an adjusted item, which does not affect the adjusted operating profit, nor the financial...

Continue reading

TELESTE KIRJAA KERTALUONTEISEN 3,2 M€ ERÄN LIIKETOIMINNAN MUIHIN TUOTTOIHIN

TELESTE OYJ    SIJOITTAJAUUTINEN    23.03.2021 KLO 13:00 TELESTE KIRJAA KERTALUONTEISEN 3,2 M€ ERÄN LIIKETOIMINNAN MUIHIN TUOTTOIHIN Teleste kirjaa kertaluonteisen 3,2 miljoonan euron erän liiketoiminnan muihin tuottoihin tilikauden 2021 ensimmäisellä neljänneksellä. Tuotto liittyy maaliskuussa 2019 tiedotettuun rikokseen. Aikaisemmin 2019 tilinpäätöksessä raportoidun lisäksi varoja pystytään kuluvan vuosineljänneksen aikana palauttamaan 3,2 miljoonaa euroa korvauksina vakuutusyhtiöiltä (palautukset yhteensä noin 3,9 miljoonaa euroa). Yhtiö pitää epätodennäköisenä, että rikoksen seurauksena menetettyjä varoja pystyttäisiin palauttamaan myöhemmin lisää. Yhtiö raportoi kertaluonteisen tuoton oikaisueränä, joka ei vaikuta oikaistuun liiketulokseen eikä vaikuta yhtiön aikaisemmin tiedottamiin taloudellisiin näkymiin. TELESTE OYJ Jukka RinnevaaraToimitusjohtaja LISÄTIETOJA:...

Continue reading

BioNTech to Report Full Year Financial Results for 2020 and Provide Corporate Update on the Fourth Quarter on March 30, 2021

Mainz, Germany, March 23, 2021 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the fourth quarter 2020 on Tuesday, March 30th, 2021. BioNTech invites investors and the general public to join a conference call and webcast with investment analysts on the same day at 8.00 a.m. EDT (2.00 p.m. CET) to report its financial results and provide a corporate update on the fourth quarter and full year 2020. The slide presentation and audio of the webcast will be available via the following link: https://edge.media-server.com/mmc/p/j78pn8zg To participate in the conference call, please dial the following numbers ten minutes prior to the start and provide the Conference ID:United States international:United States domestic (toll-free):Germany:Conference ID: +1 646 741 3167+1 877...

Continue reading

BioNTech veröffentlicht am 30. März 2021 Ergebnisse des Geschäftsjahres und informiert zum operativen Fortschritt im vierten Quartal 2020

MAINZ, Deutschland, 23. März 2021 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, „BioNTech” oder „das Unternehmen“) wird am Dienstag, den 30. März 2021, die Ergebnisse des vierten Quartals 2020 veröffentlichen. BioNTech wird außerdem am selben Tag um 14.00 Uhr MESZ eine Telefonkonferenz samt Webcast mit Investment-Analysten anbieten, um die Quartalsergebnisse sowie ein Unternehmensupdate für das vierte Quartal und das gesamte Geschäftsjahr 2020 zu präsentieren und lädt Investoren und die allgemeine Öffentlichkeit ein, daran teilzunehmen. Die Präsentation wird samt Ton über den folgenden Webcast-Link verfügbar sein: https://edge.media-server.com/mmc/p/j78pn8zg Einwahldaten für die Telefonkonferenz in englischer Sprache:DeutschlandStandard International:Zugangscode: +49 (0) 692 2222 625+44 (0) 2071 9283384038477Bitte wählen Sie sich...

Continue reading

Emerging Markets Report: Medical Technology Disruptor

An Emerging Markets Sponsored Commentary ORLANDO, Fla., March 23, 2021 (GLOBE NEWSWIRE) — Medical Technology Disruptor. Normally, we write our own headlines for the pages of the Emerging Market Report but in this instance there is no finer title than the one that adorns the Company’s homepage. And frankly, it is one of our peak areas of interest. We’ve been frank about the epic changes that the pandemic has created and our fervent goal to participate in COVID driven trends. There are very few good things about this awful disease but some of the changes in health care for which it has been catalytic are among them. Paramount among them, we believe, will be telehealth and testing enhancements. As such, let’s take a look at Medivolve Inc. (“Medivolve” or the “Company”) (NEO:MEDV; OTC:COPRF; FRA:4NC)  The company offers investors a...

Continue reading

Emerging Markets Report: A Marriage Made in Manama

An Emerging Markets Sponsored Commentary ORLANDO, Fla., March 23, 2021 (GLOBE NEWSWIRE) — As rabid fans of the fintech space we are pleased to continue to report on AppTech Corp. (OTC: APCX), a financial technology company utilizing innovative payment processing technologies to complement its core merchant services capabilities. Its patented and proprietary software for merchant services, text marketing and lead generation are licensable or available through a suite of synergistic offerings. That’s the description from the Company and plainly spoken, AppTech is innovating within Fintech with novel product offerings including a text payment app we reported on previously. Click here to read “A Bright Future for Fintech and FinTEXT” AppTech Corp. (OTC: APCX) and NEC Payments B.S.C(c) announced on March 08, 2021, the financial closure...

Continue reading

Emerging Markets Report: A Psychedelic Solution to a National Crisis

An Emerging Markets Sponsored Commentary ORLANDO, Fla., March 23, 2021 (GLOBE NEWSWIRE) — Today’s featured company is emerging in a new lane of health care that we believe could be revolutionary. Please allow us to introduce Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH). Let’s start with the Company mission statement: “MINDCURE is focused on finding new ways to treat the profound distress of a world suffering from a mental health crisis. This is a tremendous opportunity to bring a new category of psychoactive and psychedelic treatments to market.” It’s a bold statement for sure but unless you’ve had your power out the last year you’ve seen the tremendous amount of new interest in psilocybin and psychedelics specifically for mental health applications. Here are a few bullets to consider before we discuss what’s novel...

Continue reading

Emerging Markets Report: A Tipping Point

An Emerging Markets News Commentary ORLANDO, Fla., March 23, 2021 (GLOBE NEWSWIRE) — Recent news from U.S.-based restaurant chain operator, Franchisor, and product distributor, Kisses From Italy, Inc. (OTCQB:KITL), begs the obvious question… is the Company at a tipping point? We come to this question after a lengthy term of service, telling the Kisses story to the market. First we talked about how their offerings caught fire in the home shopping craze over the past year and then their early successes in brick and mortar restaurants. Both of those separate successes were important, But now they’ve added to it in a way we think is quite significant. Very recent news confirms that Kisses’ branded products are now in twenty retail locations in Canada. So on top of the robust online sales and award winning franchise operations in the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.